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Abstract Changes in epigenetic marks such as DNA
methylation and histone acetylation are associated with a
broad range of disease traits, including cancer, asthma,
metabolic disorders, and various reproductive conditions. It
seems plausible that changes in epigenetic state may be
induced by environmental exposures such as malnutrition,
tobacco smoke, air pollutants, metals, organic chemicals,
other sources of oxidative stress, and the microbiome,
particularly if the exposure occurs during key periods of
development. Thus, epigenetic changes could represent an
important pathway by which environmental factors influ-
ence disease risks, both within individuals and across
generations. We discuss some of the challenges in studying
epigenetic mediation of pathogenesis and describe some
unique opportunities for exploring these phenomena.
Abbreviations
ART Assisted reproductive technologies
ASM Allele-specific DNA methylation
ChIP Chromatin immunoprecipitation




feNO Fractional exhaled nitric oxide
FFPE Formalin-fixed paraffin-embedded
HDAC Histone deacetylases
iNOS Inducible nitric oxide synthase
IUGR Intra-uterine growth restriction
IVF In vitro fertilization
PBMCs Peripheral blood mononuclear cells
PTS Maternal smoking during pregnancy
SNP Single nucleotide polymorphism
Background
The field of epigenetics grew from attempts, beginning
over 70 years ago, to understand mechanisms whereby
multiple cellular phenotypes arise from a single genotype
during the complex process of developmental morpho-
genesis termed epigenesis. The term ‘‘epigenetics’’ was
initially reserved for mechanisms by which phenotypic
state, as determined by differential gene expression, could
be stably retained through cell division by non-genetic
factors. Various mechanisms have been proposed to have
the potential to encode this phenotypic information; these
include enzymatic methylation of cytosine bases (DNA
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methylation), post-translational modification of tail
domains of histone proteins (histone modifications) and
associated nucleosome positioning or chromatin remodel-
ing, non-coding RNAs, and transcription factor regulatory
networks (Ptashne 2007). Epigenetic marks established by
each of these processes are often shared within a cell lineage;
however, whether all persisting epigenetic marks satisfy
requirements for stable transmission through cell division or
some are merely reestablished from other information fol-
lowing mitosis remains a vigorously debated question.
The term epigenetics has more recently been used in the
scientific literature to describe various unspecified non-
genetic mechanisms influencing phenotype. This broader
usage emerged from mouse studies addressing transgen-
erational nutritional effects on phenotype, as well as human
studies of phenotypic differences between monozygotic
twins. In the popular press ‘‘epigenetics’’ has become
almost synonymous with nutritional and environmental
influences on gene expression. Thus, while ‘‘epigenetics’’
initially referred to largely self-contained developmental
processes, it has come to describe environmental influences
on phenotypic readout of genotypes. This semantic evo-
lution has caused confusion and controversy regarding the
meaning of ‘‘epigenetics’’ at a time of intensified interest in
the possible role of epigenetic mechanisms in disease. In
this review we define as epigenetic processes those that
stably affect gene expression through mechanisms not
involving the primary nucleotide sequence, and epigenetic
state as the configuration of chromatin and DNA marks
utilized by these processes. By contrast, genetic state is
widely understood to refer to the primary nucleotide
sequence itself, while genetic processes maintain or change
nucleotide sequence.
Epidemiologic research addressing epigenetic mecha-
nisms as mediators of environmental exposures on disease
risk is constrained by important ethical considerations.
These often preclude both experimental exposure to candi-
date environmental causes, and invasive collection of cell
types of greatest developmental and functional relevance to
disease processes. Inquiry has therefore progressed largely
by integrating information about biological mechanisms
obtained in model systems with observational data provided
by humans. To address the current state and future promise of
this research, we undertook this review with two goals: to
illustrate the potential of epigenetic processes to mediate
exposure–phenotype relationships and to discuss study
design and statistical analysis methods needed to investigate
such mechanisms in relation to origins of human disease. We
begin by discussing genetic, developmental, and environ-
mental determinants of epigenetic state in human and model
systems, then describe some of the diverse data implicating
epigenetic mechanisms in various human diseases, both
within individuals and across generations. We conclude by
discussing technical challenges, suggesting promising
opportunities for epidemiologic research in environmental
epigenetics, and offering some thoughts about translational
significance and future directions of this field.
Determinants of epigenetic state
Epigenetic mechanisms work in concert to influence the
potential for gene expression at myriad locations through-
out the genome. The resulting epigenetic state of the gen-
ome, termed epigenome, varies by cell type. Considering
the tremendous diversity of epigenetic marks, which
include dozens of different post-translational histone
modifications and more than 50 million sites of potential
DNA methylation in a diploid human genome (and thus
[250M possible epigenotypes!), it seems that no two human
cells would have identical epigenomes. Indeed, within each
individual there are many epigenomes, and these change
over time as a consequence of both normal developmental
and pathological processes, as well as environmental
exposures and random drift. Despite this potential for
considerable variability of epigenetic patterns within and
between individuals, there can also be remarkable consis-
tency. In a study of 11 tissues in 6 autopsies, DNA meth-
ylation patterns in a highly selected set of loci were found
to be highly conserved, with intraclass correlations of 0.85
across tissues within individuals and 0.83 across individ-
uals within tissues (Byun et al. 2009). The authors inter-
preted these patterns as revealing different sets of person-
specific and tissue-specific differentially methylated genes,
anticipating subsequently observed differential genetic and
acquired determination (Waterland et al. 2010).
DNA methylation has been the epigenetic mark most
extensively measured in epidemiologic research for numerous
reasons. It is of fundamental biological interest owing to its
unambiguously stable transmission during cell division. It
also has practical advantages: as a chemically stable covalent
change to the DNA itself, DNA methylation is the only epi-
genetic mark that survives the DNA extraction and purifica-
tion that is routine in molecular sample processing, and it can
endure decades of archival sample storage (Kristensen et al.
2009).
Genetic influences
Nucleotide sequence is a primary determinant of epigenetic
state, clearly evident from the distribution of epigenetic marks
across the genome, determined in part by direct effects of G:C
content and CpG (cytosine-phosphate-guanine dinucleotide)
density (Tanay et al. 2007; Thomson et al. 2010). Additional
genetic influences include proximity to repetitive elements
such as Alu and LINE1 (Estecio et al. 2010), nuclear
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architecture (Berman et al. 2011), and binding sequences for
transacting proteins (Bell et al. 2011b; Weth and Renkawitz
2011). Motif searches and screening strategies have identified
sequence elements that predispose to particular epigenetic
states (Feltus et al. 2006; Ideraabdullah et al. 2011; Keshet
et al. 2006; Lienert et al. 2011).
Several lines of evidence indicate that genetic poly-
morphisms can affect epigenetic state. Greater differences
were observed between dizygotic co-twins than between
monozygotic co-twins in two forms of epigenetic state:
skewed patterns of X-inactivation, and DNA methylation at
differentially methylated regions of the imprinted IGF2/
AH19 locus (Wong et al. 2011; Heijmans et al. 2007;
Ollikainen et al. 2010). Extensive DNA methylation anal-
yses in a multigenerational family revealed that epiallelic
similarity was greater among first-degree relatives than
among more distantly related family members. In the same
study, analyses addressing both genetic variation and DNA
methylation identified widespread occurrence of allele-
specific DNA methylation (ASM) that was associated with
polymorphic nucleotides located near the DNA methyla-
tion site, but not parent of origin. Authors of this report
concluded that the majority of such ASM events depend on
cis-acting DNA sequence (Gertz et al. 2011). Such ASM
events have yet to be characterized in large population-
based studies, but more modest studies addressing hetero-
zygous non-imprinted loci have identified widespread
ASMs associated with nearby genotypic polymorphisms in
DNA from multiple tissue types (Kerkel et al. 2008; Tycko
2010; Schalkwyk et al. 2010), as well as allele-specific
chromatin structure and transcription factor binding in
lymphoblastoid cell DNA (McDaniell et al. 2010, reviewed
in Birney et al. 2010). Presumed transgenerational inheri-
tance of epigenetic changes (‘‘epimutations’’) in the MLH1
(Suter et al. 2004) and MSH2 (Chan et al. 2006) mismatch
repair genes, both associated with colorectal cancer, were also
traced to germline genetic variation. In the case of the MSH2
epimutation, deletion of a gene immediately upstream of the
MSH2 gene causes transcription to run through the MSH2
promoter, causing somatic hypermethylation and gene
silencing (Ligtenberg et al. 2009). The MLH1 epimutation
was found to be caused by a polymorphism in the 50 UTR of
the MLH1 gene, reducing transcriptional activity, and pre-
disposing to aberrant somatic DNA methylation in each
generation (Hitchins et al. 2011).
Developmental programming of the epigenome
In successful mammalian reproduction, the single-cell zygote
gives rise to an organism with hundreds of cell types. These
diverse cellular phenotypes arise from the same shared
genomic sequence by control of the subset of genes expressed
in each cell type. Cellular differentiation is tightly linked to
extensive erasure and establishment of lineage-specific epi-
genetic marks, a process termed epigenetic reprogramming.
Relatively detailed descriptions of DNA methylation in
developing tissues have been carried out in the mouse, which
serves as a model of epigenetic reprogramming in mammalian
development (Trasler 2009).
At fertilization, reprogramming begins with extensive
erasure of methyl marks in DNA of the paternal (sperm-
derived) DNA, followed by more general loss of methyl marks
in the zygote and embryo during cleavage divisions, while
sparing parent-of-origin specific imprints. By the blastocyst
stage, de novo DNA methylation distinguishes inner cell mass
cells (from which embryonic lineages arise to create fetal
structures) from relatively hypomethylated trophectoderm
cells (from which extra-embryonic lineages arise to create
transient structures, including placenta) (Fig. 1).
Germ cell lineage specification begins in cells of the
proximal epiblast, and involves a second extensive erasure of
DNA methylation that removes parental imprint marks
(Fig. 1). Thereafter, the germ line develops in a sexually
dimorphic fashion. New DNA methyl marks are established
over many stages, extending through sexual maturity in
accordance with the sex of the developing individual. At this
time, the sex-specific imprint marks that govern parent-of-
origin specific expression of imprinted genes in the sub-
sequent generation are established (Faulk and Dolinoy 2011).
Developmental reprogramming can result in dramatic
epigenetic differences between the two alleles. The asso-
ciation between mono-allelic gene expression and DNA
methylation has long been recognized, both in the context
of X-inactivation in females (Boggs et al. 2002; Sharp et al.
2011) and in parent-of-origin determined genomic
imprinting (Ferguson-Smith 2011), but now also in the
mono-allelic expression of non-imprinted autosomal loci
(Harris et al. 2010; Tarutani and Takayama 2011).
Further resetting of epigenetic marks accompanies differ-
entiation of many specialized cell types of the body as well as
placenta and other transient structures during pregnancy, and
subsequent development of body structures during various
postnatal stages of development. Chromatin states that arise
during development can affect the propensity to subsequent
epigenetic change. An example of this is the predisposition of
polycomb-repressive complex occupied genes in stem cells to
the acquisition of DNA methylation abnormalities in aging
and cancer (Ohm et al. 2007; Schlesinger et al. 2007;
Teschendorff et al. 2010; Widschwendter et al. 2007).
Environmental influences
Multiple differences in gene expression, presumably
reflecting intrauterine epigenetic differences, have been
identified in several tissues from newborn identical twins
(Gordon et al. 2011). The global methylation pattern of
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individuals changes with increasing age (Bjornsson et al.
2008), as does the difference in global methylation between
MZ twin pairs (Fraga et al. 2005). Genetically identical MZ
twins show some epigenetic discordance at birth, as indi-
cated by gene expression discordance (Gordon et al. 2011).
Even over the first decade of life (Wong et al. 2010), and as
aging adults (Talens et al. 2010), MZ twins acquire addi-
tional differences in epigenetic state, which may partly
reflect different exposure histories, as would be expected if
environmental exposures influence epigenetic state. How-
ever, stochastic drift in epigenetic state and related con-
sequences such as mono-allelic expression described in the
previous section is likely responsible for much of the
observed divergence. Therefore, other forms of data (dis-
cussed below) are needed to determine what type of
exposures may influence epigenetic state and the extent of
resulting changes.
Experimental studies
The most direct evidence suggesting that ambient exposures
may influence epigenetic state is experimental. In vitro
studies have demonstrated associations of DNA methylation
with various metals (Dolinoy et al. 2007b; Wright and
Baccarelli 2007). In the in vivo setting, prenatal protein
restriction is associated with hypomethylation of the gluco-
corticoid receptor (GR) and PPARa gene promoter regions in
rat liver (Lillycrop et al. 2005), changes that were prevented
by folic acid supplementation (Lillycrop et al. 2005) and
which were transmitted to the F2 generation (Burdge et al.
2007). Plagemann et al. (2009) found hypermethylation in
the promoter of the anorexigenic gene for proopiomelano-
cortin in rats overfed as neonates. Whether this change could
be transmitted to offspring was not assessed. DNA from
sperm of mice exposed to steel plant air was found to be
persistently hypermethylated long after exposure ended
(Yauk et al. 2008). Additionally, maternal nurturing behav-
ior has been shown to modify methylation at individual CpG
sites in the ngf1a binding region of the GR gene in the hip-
pocampus of the offspring (Weaver et al. 2004), an epige-
netic modification that persisted both into adulthood to
modify response to stress, and into the F2 generation.
Human studies
Christensen and Marsit (2011) and Terry et al. (2011) have
provided comprehensive reviews of environmental influ-
ences on epigenetic state in humans. Here we note expo-
sure periods of particular interest and several examples of
environmental exposures reportedly associated with epi-
genetic state of specific human cell types.
The epigenome may be most vulnerable to environ-
mental insults during periods of extensive epigenetic
reprogramming, which may in theory be disrupted by
Fig. 1 Reprogramming of
DNA methylation in the zygote,
early embryo, and primordial
germ cells. Thickness of the
outer arrows indicates levels of
DNA methylation. Red maternal
genome, blue paternal genome,
black diploid genome.
Embryonic lineages arise from
cells of the inner cell mass
(ICM), the placenta and
extraembryonic membranes
from trophectoderm cells, and
the germ cell lineage from
primordial germ cells following
their determination from
proximal epiblast. Inner circles
indicate developmental stages
when key elements of
epigenetic programming are
thought to occur (Adapted from
Feng et al. 2010)
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exposures that interfere with any process that governs
reprogramming. Periods of particular vulnerability may
therefore include the early stages of embryonic develop-
ment mentioned above. Childhood is also proposed as a
period of vulnerability, especially in the germline of
females, since oocytes remain in a haploid de-methylated
state until puberty, so environmental insults may poten-
tially disturb the epigenetic state of the oocyte for many
years (Faulk and Dolinoy 2011), with potential implica-
tions for both fertility and initial epigenetic state of off-
spring of an exposed female. Somatic changes to DNA
methylation may also result from environmental exposures
in adults, as have been observed in aging and disease
processes such as cancer described in the next section.
Energy and nutrient intake
Significant epigenetic changes in the IGF2 gene have been
documented in those prenatally exposed to severe caloric
restriction during the Dutch hunger winter of World War II
(Heijmans et al. 2008). Hughes et al. (2009) additionally
found that those most likely to be exposed to this famine
during adolescence or young adulthood had a significantly
decreased risk of developing colorectal cancers (CRC)
characterized by the CpG island methylator phenotype
(CIMP), suggesting a role for early life exposures in CIMP-
specific CRC pathogenesis.
Folates are the major source of the methyl groups used
for DNA and histone methylation. One study of folates and
other one-carbon nutrients reported a differential effect of
folate on the risk of the CIMP CRC subset compared to the
non-CIMP subset (Van Guelpen et al. 2010), while two
other studies did not (Slattery et al. 2006; van den Donk
et al. 2007). Most studies of the microsatellite instability
high subset, characterized by hypermethylation of the
MLH1 gene promoter region and CIMP (Weisenberger
et al. 2006), have yielded similarly negative results (Eaton
et al. 2005; Schernhammer et al. 2008; Slattery et al. 2001;
Wark et al. 2005). On the other hand, in some studies the
association between intake of alcohol (which degrades
folates) and CRC risk has been reported to be greater in
MSI-H and CIMP tumors (Diergaarde et al. 2003; Eaton
et al. 2005; Slattery et al. 2001).
Micro-RNAs (miRNAs) are very short non-coding RNA
molecules that can downregulate protein-coding genes by
destabilizing mRNAs or blocking translation. The possi-
bility that exogenous microRNA consumed in food may
epigenetically regulate gene expression has emerged from
recent studies demonstrating the presence of plant-derived
miRNAs in sera of humans and other mammals (Zhang
et al. 2012). One of these plant microRNAs, MIR168a,
which was demonstrated to be only of plant origin in control
mice, binds coding sequence of the mammalian LDLRAP1
gene in vitro. Functional consequences in mammalian sys-
tems were demonstrated experimentally, as MIR168a
administered in vitro and during in vivo feeding studies
decreased expression of the protein product of LDLRAP1.
This line of research suggests novel epigenetic mechanisms
whereby diet may modify risk of human disease.
Air pollution
Emerging evidence suggests that air pollutants can influ-
ence epigenetic changes, including DNA methylation as
well as up- or down-regulation of miRNAs (Jardim 2011).
In human epidemiologic studies, PM2.5 and PM10 expo-
sures are associated with hypomethylation of Alu and/or
LINE1 elements in leukocytes and buccal cells (Baccarelli
et al. 2009; Bollati and Baccarelli 2010; Madrigano et al.
2011; Salam et al. 2012; Tarantini et al. 2009), as well as
altered DNA methylation in NOS2A, a gene involved in
production of nitric oxide (Salam et al. 2012; Tarantini
et al. 2009). Living in highly polluted cities (high PM and
ozone) is also associated with hypermethylation of FOXP3
in regulatory T cells (Nadeau et al. 2010), while neonates
who were prenatally exposed to polyaromatic hydrocarbon
(PAH) had hypermethylated ACSL3 in DNA of umbilical
cord white blood cells (Perera et al. 2009); notably, both of
these genes are involved in asthma pathogenesis. PAHs are
also associated with hypermethylation of LINE1 and Alu
(Pavanello et al. 2009; Perera et al. 2009). More limited
evidence is emerging to suggest that air pollution is asso-
ciated with changes in miRNA expression (Bollati et al.
2010; Jardim 2011), and adverse effects of air pollution
constituents may be modified by variant alleles of genes
involved in miRNA processing (Wilker et al. 2010).
Tobacco smoke
Fetal exposure to maternal smoking during pregnancy
(PTS) is associated with reduced methylation of several
repeated sequences, including Sat2 (Flom et al. 2011), Alu,
and LINE1 among children with the GSTM1 null genotype
(Breton et al. 2009). PTS exposure is also associated with
increased DNA methylation in specific genes, such as AXL
and PTPRO (Breton et al. 2009, 2011b) and IGF2 (Murphy
et al. 2011). In adult lung cancer patients, quantity and
duration of active smoking as well as second-hand smoke
is associated with increased DNA methylation of p16 (Kim
et al. 2001; Scesnaite et al. 2012), MGMT, and DAPK
(Russo et al. 2005). Tobacco smoke is also associated with
tumor cell DNA methylation changes in esophageal squa-
mous cell carcinoma (Huang et al. 2011), significantly
higher frequencies of abnormal DNA hypermethylation in
Hum Genet (2012) 131:1565–1589 1569
123
prostate (Enokida et al. 2006) and gastric cancers tumor
cells (Nan et al. 2005) and with a higher risk of
CIMP ? colorectal tumors (Limsui et al. 2010; Samowitz
et al. 2006). Lastly, the F2RL3 gene is hypomethylated in
smokers and may mediate the detrimental impact of
smoking on cardiovascular mortality, since hypomethylat-
ed F2RL3 was found to be strongly associated with car-
diovascular mortality among patients with stable coronary
heart disease (Breitling et al. 2012).
Oxidative stress
Reactive oxygen species (ROS) are involved in numerous
cellular processes including cellular redox alterations,
immune response, signaling pathways, chromatin remod-
eling and gene expression (Sundar et al. 2010). ROS have
the potential to influence epigenetic mechanisms (Baccar-
elli and Bollati 2009), and have been shown to inhibit
binding of methyl-CpG binding protein 2, a critical epi-
genetic regulator that recruits cytosine methyl transferases
and histone deacetylases to DNA (Valinluck et al. 2004).
Numerous environmental exposures, including constituents
of air pollution and tobacco smoke, can generate ROS and
thus may potentially alter epigenetic processes through
oxidative stress mechanisms.
Metals
Prenatal lead exposure is associated with decreased meth-
ylation of LINE1 and Alu in cord blood (Pilsner et al.
2009), and a similar pattern of LINE1 methylation was
reported in an elderly cohort (Wright et al. 2010). Studies
in humans have shown that arsenic exposure is associated
with either global hypermethylation or hypomethylation in
peripheral blood mononuclear cells (PBMCs) depending on
dose (Majumdar et al. 2010), as well as DNA hyperme-
thylation of several genes, including CDKN2A (Chanda
et al. 2006), RASSF1A and PRSS3 (Marsit et al. 2006).
Exposure to airborne particulates rich in lead, cadmium
and chromium are associated with miRNA expression in
peripheral blood (Bollati et al. 2010) and airborne levels of
nickel and arsenic are positively correlated with both his-
tone 3-lysine4 trimethylation (H3K4me3) and histone
3-lysine9 acetylation (H3K9ac) in blood leukocytes
(Cantone et al. 2011). Occupational exposure to nickel is
associated with increased H3K4me3 and decreased
H3K9me2 in PBMCs (Arita et al. 2011). Lastly, cadmium
can induce overexpression of the DNA methyltransferase
genes DNMT1 and DNMT3a in human embryo lung
fibroblasts, and is associated with hypermethylation and
silencing of the MSH2, ERCC1, XRCC1 and OGG1 genes
in human bronchial epithelial cells (Jiang et al. 2008; Zhou
et al. 2011).
Organic chemicals
Gas-station attendants and police officers occupationally
exposed to low levels of benzene were found to have
significantly lower LINE1 and Alu methylation, hyper-
methylation of p15, and hypomethylation of MAGE-1 in
blood (Bollati and Baccarelli 2010; Bollati et al. 2007).
Genetic 9 epigenetic 9 environmental interactions
Most work investigating effects of environmental factors on
epigenetic state has not considered the potential for genetic
susceptibility to modify these associations. However, Salam
et al. (2012) recently investigated contributions of both
genetic and epigenetic variation in air pollution-mediated
levels of fractional exhaled nitric oxide (feNO). Measure-
ment of feNO provides an in vivo summary assessment of
inducible nitric oxide synthase (iNOS) activity as well as
airway inflammation. These investigators found interrelated
effects of exposure to the air pollution constituents PM2.5,
NOS2A promoter haplotypes, and methylation of the iNOS
encoding gene NOS2A and NOS2 promotor haplotypes on
feNO level. These observations illustrate not only the feasi-
bility of assessing interactions between epigenetic, genetic,
and environmental factors, but also the importance of doing
so in order to delineate complex biological relationships and
identify susceptible subpopulations.
Epigenetic effects in human disease
Conditions associated with improper parental contributions
of imprinted genes are currently the clearest examples of
human diseases related to epigenetic state. Even before
genomic imprinting was described, experiments in which
pronuclei were transplanted into enucleated eggs demon-
strated that both maternal and paternal chromosomal con-
tributions are required for normal development. Control
conceptuses receiving one set (haploid genome) of mater-
nal (egg-derived) and one set of paternal (sperm-derived)
chromosomes could develop normally. However, abnormal
development and early demise occurred in all conceptuses
receiving either two maternal sets or two paternal sets of
chromosomes (McGrath and Solter 1984), which devel-
oped into tissues with histologic features of dermoid cysts
and hydatiform moles, respectively.
Model imprinting disorders such as Beckwith–Wiede-
mann, Angelman, Russell–Silver, and Prader–Willi syn-
dromes are human conditions that can be caused by
aberrant epigenetic state (Ferguson-Smith 2011). The
specific features, early onset, and rarity of these disorders
facilitated recognition of their relation to improper parental
contributions of imprinted loci (e.g. two maternal or two
1570 Hum Genet (2012) 131:1565–1589
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paternal copies, rather than one maternal and on paternal
copy), which can arise from uniparental disomy, more local
epigenomic abnormalities (Tierling et al. 2011), or widely
distributed changes caused by genetic defects in trans-
acting epigenetic regulators (Begemann et al. 2011).
The role of epigenetics in most other conditions remains
far less clear. However, since Barker proposed that there is
sometimes a fetal basis for adult disease (Barker et al.
1993), epidemiologic research has implicated numerous
environmental exposures during prenatal and early post-
natal development as influencing risk of adult cardiovas-
cular disease, obesity, type 2 diabetes, and other chronic
conditions (Taylor and Poston 2007). Epigenetic processes
have been proposed to explain lengthy time periods
between exposure and disease onset: if exposures during
early periods of epigenetic vulnerability influence epige-
netic state, resulting epigenetic marks may be stably
maintained in cell lineages to influence disease suscepti-
bility years later. Waterland and Jirtle (2004) and Lillycrop
(2011) recently discussed experimental data addressing the
plausibility of such mechanisms. Human research descri-
bed here provides correlative data. Associations between
exposure history and epigenetic state are described in the
previous section, while associations between epigenetic
state and disease risk are outlined below, with a few studies
reporting associations over the exposure—epigenetic
state—disease continuum.
Reproductive conditions
The possibility that epigenetic state can influence repro-
ductive success was recognized once research in model
organisms revealed that dramatic epigenetic reprogram-
ming occurs during gametogenesis, fertilization, and
development of the zygote, embryo and placenta (Feng
et al. 2010). Ethical considerations have limited studies that
directly measure epigenetic state to a small subset of
relevant cell types and developmental stages. Here we
review selected data addressing the hypothesis that epige-
netic phenomena may influence risk of infertility, disorders
of placental development and function, and birth weight.
Human infertility research has assessed DNA methyla-
tion profiles in DNA isolated from spermatozoa, fully
differentiated male germline cells that are amenable to
noninvasive collection. Although neither measures of DNA
methylation nor outcomes have been standardized across
published studies, most report variation in epigenetic state
of sperm DNA to be associated with undesirable outcomes
(Carrell and Hammoud 2010). Early studies employing
methylated cytosine immunostain—a genome-wide mea-
sure without sequence specificity—revealed little differ-
ence between sperm DNA methylation and sperm quality
(Benchaib et al. 2003) or fertilization rate and embryo
quality following in vitro fertilization (IVF) (Benchaib
et al. 2005). However, all subsequent studies assaying
specific sequence elements (Pacheco et al. 2011, reviewed
in Cortessis et al. 2011; van Montfoort et al. 2012) reported
abnormal methylation of one or more imprinted genes in
DNA from poor quality sperm, as predicted if sperm pro-
duction defects involve deregulated imprinting (Filipponi
and Feil 2009). Three studies assaying repeated elements
reported no association between sperm quality and meth-
ylation of Alu (Kobayashi et al. 2007) or LINE1
(Houshdaran et al. 2007; Marques et al. 2008), while one
reported elevated Alu methylation in sperm used in assisted
reproductive technologies (ART) leading to pregnancy and
live birth (El Hajj et al. 2011) and another that poor sperm
quality was associated with hypermethylation of the
repetitive element SAT2CHRM1 (Houshdaran et al. 2007).
Studies interrogating CpG islands not associated with
recognized imprints reported methylation at numerous sites
to be associated with sperm quality, implicating wide-
spread disruption of DNA methylation in abnormal sper-
matogenesis (Houshdaran et al. 2007; Pacheco et al. 2011).
This avenue of research is expanding to address additional
epigenetic marks of specific relevance to the male germline
(Carrell and Hammoud 2010; van Montfoort et al. 2012).
Early stages of germ cell development are reportedly
identical in both sexes, so early disruptions of epigenetic
state could in theory impair fertility of both males and
females. However, direct epigenetic study of female gametes
is not regarded as practicable, because very few oocytes are
produced, and oocyte retrieval procedures may alter epige-
netic state (Fortier et al. 2008; Li et al. 2011; Sato et al. 2007).
Epigenetic state has also been implicated in infertility by
a distinct form of data, excess occurrence of model
imprinting disorders among children conceived by ART
(van Montfoort et al. 2012). A recent meta-analysis found
elevated occurrence of imprinting disorders of both mater-
nal origin (Angelman syndrome, Beckwith–Wiedemann
syndrome) and paternal origin (Prader–Willi syndrome)
(Cortessis 2009). Because only sub-fertile individuals use
ART, these results could indicate a tendency for sub-fertile
adults to produce gametes with inappropriately set imprint
marks. However, whether underlying molecular defects of
these children are epigenetic or genetic was not reported,
and even if they were epigenetic, alternate explanations are
credible. Couples undergoing ART are dissimilar to the
general population with respect to age and income and thus
numerous unmeasured factors that could be postulated to
influence epigenetic state. Moreover, ART procedures
bypass various functions that accompany unassisted con-
ception. These include the need for spermatozoa to traverse
the female reproductive tract and compete to penetrate the
oocyte, which may serve to select for fertilization sperm
with normal epigenetic state. Finally, effects of ART
Hum Genet (2012) 131:1565–1589 1571
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themselves have been postulated, since some imprinting
disorders share overgrowth features of the veterinary con-
dition large offspring syndrome, which appears to be
inducible by embryo culture (Sinclair et al. 2000). How-
ever, data on epigenetic state of human oocytes and
embryos are extremely limited (van Montfoort et al. 2012).
Fetal survival, development and growth depend upon the
placenta. Arising from the relatively hypomethylated TE,
cells of the developing placenta undergo extensive de novo
DNA methylation (Serman et al. 2007). Epigenetic regu-
lation of placental function changes during gestation
(reviewed in Nelissen et al. 2011), accompanied by a
dynamic process of loss of imprinting postulated to have an
important role in placental maturation and function (Po-
zharny et al. 2010). Unidentified placental functions are
postulated to rely on imprinting, because imprinted genes
are abundantly expressed in the placenta, compared with
other organs, and imprinting arose during mammalian
evolution (Nelissen et al. 2011). Disturbed placental
function may cause intra-uterine growth restriction
(IUGR), a predictor of poor health in the neonatal period
and childhood, which may also predispose to diseases of
adulthood. Two small studies examining mRNA transcript
levels in placentas of IUGR and normal birthweight infants
reported differential expression of some placentally
imprinted genes (Diplas et al. 2009; McMinn et al. 2006); a
third reported lower IGF2 and loss of IGF2 imprints
(Koukoura et al. 2011a) as well as higher H19 transcript
levels and increased H19 expression (Koukoura et al.
2011b) in growth-restricted placentas. Differential levels of
transcripts encoded by individual imprinted loci were also
reported in IUGR placentas (Apostolidou et al. 2007) and
small for gestational age infants (Guo et al. 2008).
Infants conceived by ART have been shown consistently
to have lower birthweight than other infants (Andersen et al.
2008). A recent meta-analysis revealed that in published
studies of singleton births controlled for effects of maternal
age, low birthweight was more common among those con-
ceived by IVF (McDonald et al. 2009). In the same review,
IVF conception was also associated with premature birth,
which is highly associated with low birthweight. Similar
analyses indicate that low birthweight and preterm birth are
also more common among twins conceived by IVF com-
pared with naturally conceived twins (McDonald et al.
2010). Addressing ART procedures more generally, recently
published surveillance data on over 16,000 births revealed
elevated occurrence of low birthweight, small-for-gesta-
tional age, and preterm birth among singleton but not twin
infants conceived following ART (D’Angelo et al. 2011).
It is presently not clear whether low birthweight fol-
lowing ART reflects epigenetic state of gametes inherited
from sub-fertile parents, effects of ART, or other unrec-
ognized factors. Additional insight may accrue from future
research addressing possible reasons that ART conception
is associated with model imprinting disorders and low
birthweight, as well as recently initiated investigation of
any relationship between epigenetic state and these out-
comes in naturally conceived neonates (Lee et al. 2012).
Asthma
Emerging evidence suggests that the epigenetic state may
contribute to asthma pathogenesis. Asthma is an IgE-
mediated type I hypersensitivity reaction involving skewed
programming of naı¨ve CD4? T lymphocytes toward a Th2
lineage (Durham et al. 2011). Shift toward a Th2 pheno-
type may result from chromatin remodeling brought about
by multiple, coordinated epigenetic changes on genes
regulating Th differentiation (Ho 2010). These include loss
of DNA methylation and gain of H3K9ac and H3L4me2 in
IL-4 and IFN-c, genes that encode key cytokines involved
in T cell lineage development (Fields et al. 2002; Jones and
Chen 2006; Kwon et al. 2008; White et al. 2002). DNA
methylation of the Foxp3, ACSL3, and ARG2 loci are
associated with impaired regulatory T-cell function
(Nadeau et al. 2010), increased asthma morbidity (Nadeau
et al. 2010; Perera et al. 2009), and exhaled nitric oxide
production, respectively (Breton et al. 2011a). Histone
deacetylases (HDACs) have also been shown to maintain
pre-established Th1-like and Th2-like immunity in human
T cells; inhibition of HDAC can shift the Th1:Th2 ratio,
skewing response toward Th2-like phenotype (Su et al.
2008). Additional evidence implicates miRNAs in asthma
pathogenesis (Pauley and Chan 2008). MiR-126 expres-
sion-suppressed asthmatic phenotype (Mattes et al. 2009)
and differentially expressed miRNAs including miR-21,
-103, -155, -146a, and -204 were identified in response
to innate and adaptive immune stimuli (Liu et al. 2009;
Nana-Sinkam et al. 2009).
Metabolic diseases
Functional epigenetic changes have been observed in
obesity (Campion et al. 2009), diabetes (Reddy and Nat-
arajan 2011), cardiovascular disease (Wierda et al. 2010),
and the constellation of abnormalities known as metabolic
syndrome (Bruce and Hanson 2010). For example, adverse
vascular effects of hyperglycemia can continue for several
years following sufficient glycemic control, a phenomenon
called metabolic memory (Siebel et al. 2010), and there is
evidence from animal studies that this effect is associated
with epigenetic changes in the promoter of the NFjb
subunit of the p65 gene in aortic endothelial cells (El-Osta
et al. 2008) and increased acetylation at H3K9/K14 in a
number of genes involved in endothelial dysfunction and
chronic inflammation (Pirola et al. 2011). In women,
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promoter-region methylation of GNSAS and INSIGF in
leucocytes was reportedly associated with an increased
incidence of myocardial infarction (Talens et al. 2011),
suggesting that epigenetic modification may be clinically
relevant. Although various histone modifications have been
demonstrated in vitro in relation to complications of
hyperglycemia (Wierda et al. 2010), permanence of indi-
vidual changes has not been established.
Neurological disorders
Historically, the field of epigenetics has focused on eluci-
dating mechanisms for maintaining DNA methylation in
dividing cells. However, recent work has discovered
dynamic DNA methylation changes in non-dividing cells
including neurons (reviewed in Mill et al. 2008), motivat-
ing studies of effects of environmental exposures on epi-
genetic marks in relation to neurological disorders.
Alzheimer’s disease, schizophrenia, and autism spec-
trum disorders show a variety of epigenetic anomalies
(Akbarian 2010; Mill et al. 2008; Nguyen et al. 2010b;
Schroeder et al. 2011). An epigenetic mechanism has been
proposed to explain the association between famine during
the prenatal period and schizophrenia risk (Lumey et al.
2011), as well as associations between expression of
imprinted genes and both autism and schizophrenia (Badcock
and Crespi 2008). Recent studies, moreover, report associa-
tions of both conditions with DNA methylation in additional,
non-imprinted genes (Dempster et al. 2011; Mill et al. 2008;
Nagarajan et al. 2006; Schroeder et al. 2011).
Cancer
Abnormal DNA methylation, histone code modifications
and miRNA changes have all been demonstrated in human
cancer cells as reviewed elsewhere (Kanwal and Gupta
2011; Lovat et al. 2011; Sharma et al. 2010). In malignant
tumors, gradual genome-wide DNA hypomethylation is
observed, concurrent with hypermethylation at normally
unmethylated CpG islands (Baylin and Jones 2011; Fein-
berg 2007). Although a direct association between hyper-
and hypo-methylation was not initially recognized (Bariol
et al. 2003; Iacopetta et al. 2007), recent work suggests that
the two phenomena may well be linked, and are confined to
similar compartments of the genome (Berman et al. 2012).
Although the targeting of abnormal hypermethylation in
gene promoter regions is not completely understood, its
association with occupancy by polycomb complex proteins
(Ohm et al. 2007; Schlesinger et al. 2007; Widschwendter
et al. 2007), which transiently repress genes involved in
differentiation, suggests that such methylation may be
associated with either de-differentiation or a failure of
tissue stem cells to fully differentiate.
Although most cancers show aberrant methylation of
some gene promoter regions, a subset of tumors is char-
acterized by CIMP, a phenotype involving concurrent
methylation of multiple gene promoter regions (Toyota
et al. 1999; Weisenberger et al. 2006). This phenotype is
best described in colorectal cancer, for which a carefully
vetted set of markers (Weisenberger et al. 2006) allows
epidemiologic studies of risk factor differences between
CIMP and non-CIMP tumors (reviewed in Curtin et al.
2011). The association between smoking and colorectal
cancer was reported to be limited to those with the CIMP
phenotype (Limsui et al. 2010; Samowitz et al. 2006).
Additionally, integration of the hepatitis B virus (HBV)
into hepatic cell DNA has been associated with increased
DNA hypermethylation in hepatocytes (Herceg and Paliwal
2011) or alternatively simply reflect a consequence of
increased cell turnover. Chronic inflammation may also
modify epigenetic marks on both histones and DNA
(Bayarsaihan 2011). Other environmental factors have also
been associated with aberrant DNA methylation in some
human studies (reviewed in Lim and Song 2012) but fur-
ther study of additional populations is needed.
The role of folates and other one-carbon nutrients,
which are critical in the provision of methyl groups, has
been assessed in many epidemiologic studies of abnor-
malities in methylation in CRC, with largely disappointing
results (Curtin et al. 2011). However, folates and poly-
morphisms in genes of the folate pathway have been shown
to modify global DNA methylation in circulating lym-
phocytes (Lim and Song 2012), although the relationship
between such changes and changes in target tissues is not
known. Additionally, the risk of various childhood malig-
nancies may be significantly decreased in children exposed
in utero to higher folate and other one-carbon nutrients,
mainly via multivitamin use (reviewed in Ciappio et al.
2011). Although a direct correlation between maternal one-
carbon nutrient levels and aberrant DNA methylation in
either childhood or adult tumors has not been demon-
strated, these studies provide a basis for future research into
the relationship between prenatal exposure to methylation-
associated nutrients and the abnormal methylation events
so common in carcinogenesis.
Transgenerational phenomena
In theory, epigenetic marks in somatic cell lineages could
be transmitted to daughter cells over the lifespan of an
exposed individual, while marks established in germ cell
lineage members could be transmitted to subsequent gen-
erations. Several examples of apparent transmission of an
environmental insult across generations are described
below. However, whether epigenetic mechanisms mediate
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these phenomena remains highly controversial (Bollati and
Baccarelli 2010). Convincing evidence that an epigenetic
mechanism is responsible for transgenerational effects
requires determination of the phenotype in at least three
generations following exposure. Taking as F0 the exposed
pregnant mother, observations of F1 through F3 genera-
tions are required to exclude the possibility of direct
effects of the exposure both on somatic cells of the F1
generation or on germ cells progenitors from which the F2
generation will arise, since both are present during the
exposed pregnancy (Perera and Herbstman 2011). It is
also possible that selection of pregnancies for viability
could influence the distribution of genes that influence
epigenetic marks.
Experimental animals
The best-documented example of transgenerational speci-
fication of a phenotype through DNA methylation is the
determination of coat color and other traits (obesity, dia-
betes, and tumors) in agouti mice. Dams carrying the meta-
stable Avy epiallele (who themselves display the agouti
coat pattern) are more likely to produce agouti offspring,
while dams of the same strain without the Avy epiallele
(who have yellow coats) are more likely to produce yellow
offspring. A continuous gradient in coat color is related to
the penetrance of the Avy epiallele (Morgan et al. 1999;
Waterland and Jirtle 2003) determined in part by methyl
donors in the dam’s diet. The phytoestrogen genistein can
also change the epigenetic state of this allele for several
subsequent generations (Cropley et al. 2006; Dolinoy et al.
2007a; Lillycrop et al. 2005). While these observations
convincingly argue for epigenetic determination of the
agouti phenotype, the meta-stable Avy epiallele arose from
insertion of a retrotransposon rather than from conven-
tional environmental exposure.
In a separate model, experimental exposure of pregnant
rats to endocrine-disrupting agents (vinclozolin, bisphenol
A) produced changes in male infertility, body weight, and
cancer risk in up to four subsequent generations (Anway
et al. 2005; Anway and Skinner 2008). However, whether
specific epigenetic marks determine this phenotype across
these generations has not been established.
Human studies
Famine
Pembrey et al. (2006) described an association between
paternal grandfather’s exposure to a famine in northern
Sweden and mortality in their grandsons, whereas paternal
grandmother’s food supply was associated instead with
mortality in their granddaughters. Lumey (1992) reported
effects on birth weight up to two generations following the
Dutch famine in World War II.
Tobacco smoke
The Southern California Children’s Health Study has dem-
onstrated an effect of grandmaternal smoking while pregnant
on the asthma risk of their grandchildren, after controlling
for maternal smoking and environmental tobacco smoke
exposure (Li et al. 2005). Pembrey et al. (2006) also
described effects of pre-adolescent paternal smoking on BMI
in sons but not daughters. Although any of these phenomena
could be due to epigenetic mechanisms, mutation to the
DNA itself would be a plausible alternative, as has been
shown for mainstream tobacco smoke (Yauk et al. 2007).
Diethylstilbestrol (DES)
Decades ago, human males exposed in utero to DES were
found to have excess occurrence of urogenital malforma-
tions, including hypospadias (Henderson et al. 1976;
Vessey et al. 1983; Whitehead and Leiter 1981), and ele-
vated prevalence of hypospadias was subsequently reported
among unexposed boys whose mothers had been exposed
in utero to DES (Brouwers et al. 2006; Klip et al. 2002;
Palmer et al. 2005; Pons et al. 2005). More recently, in a
study addressing potential competing effects of measured
environmental and genotypic factors, a notable excess of
hypospadias was reported among unexposed grandsons of
women who had been exposed in utero to DES (Kalfa et al.
2011). One postulated mechanism for these observations is
that epigenetic changes in the androgen receptor gene are
induced in primordial germ cells of DES-exposed female
fetuses at the time that the reproductive system is forming,
and subsequently transmitted across generations to affected
sons and grandsons (Kalfa et al. 2011). To our knowledge,




The long induction periods between exposure and onset of
many diseases that epigenetic mechanisms are proposed to
mediate present notable challenges to accurate assessment
of environmental exposures. Most exposures can change
over time, complicating both accurate recall and assess-
ment by short-lived biomarkers. Distinguishing exposures
of limited duration or periods of specific relevance (e.g.,
in utero) from chronic exposures may lend useful speci-
ficity for addressing some research questions. Persistent
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biomarkers (e.g., bone lead levels), when available, are
promising if the specific period of exposure is not crucial.
Exposure assessed prospectively and tightly linked to
proposed periods of vulnerability of the epigenome (e.g.,
periods of placental invasion or sex specification in utero)
would be ideal. However, this rarely occurs in epidemiol-
ogic settings with sufficient power to detect most disease
associations. However, estimating exposure–epigenetic
state associations may be more feasible.
Exposures of limited duration corresponding to disas-
ters (e.g., famine), availability of regulated or withdrawn
compounds (e.g., DES), or therapeutic indications of
limited duration (e.g., ART) can sometimes be retro-
spectively assessed with reasonable accuracy. Cohorts
based on such exposures, although rare and often small,
may be especially valuable in efforts to elucidate trans-
generational processes.
Since assessment of covariates may be equally chal-
lenging, there is considerable potential for confounding of
exposure–epigenetic state or exposure–disease associations
by factors associated with exposure, except in rare cir-
cumstances when exposure can be randomly assigned to
study participants.
Laboratory technologies
Traditional molecular biological methods of analyzing
gene loci often involve amplification through cloning,
whole-genome amplification (WGA), or polymerase chain
reaction (PCR). All of these techniques erase any existing
marks in extracted DNA or chromatin. Therefore, methods
have been developed to alter the DNA using methods
influenced by the epigenetic state prior to amplification.
The three main methods employed are affinity enrichment,
restriction digestion, and chemical conversion by sodium
bisulfite (Laird 2010). Affinity enrichment is appropriate
for most epigenetic marks, generally relying on the use of
an antibody specific for the mark of interest to enrich for
DNA sequences containing the relevant mark by chromatin
immunoprecipitation (ChIP). Affinity enrichment can also
be used for DNA methylation, but restriction digestion with
methylation-resistant and sensitive restriction enzymes has
also seen widespread use. Treatment of denatured DNA
with sodium bisulfite can convert unmethylated cytosines
to uracil, while leaving methylated cytosines intact, thus
converting epigenetic information into a genetic difference.
As microarray technology became more widespread in the
past decade, restriction enzyme and affinity-based methods
became popular. With the development of commercial
array platforms and the surging use of next-generation
sequencing, bisulfite-based methods are now the most
widely used methodology, and are well-suited for the types
of biospecimens collected in epidemiologic studies.
Biospecimens
The requirement of relatively large amounts of intact
chromatin for ChIP-chip or ChIP-seq has limited the study
of histone modifications and other protein-associated epi-
genetic marks to biospecimens with large amounts of
material with intact cells. The vast majority of studies on
ChIP have used cultured cell lines. More recently, tech-
niques to analyze small quantities of fresh tissue have been
explored (Adli and Bernstein 2011). However, none of the
existing techniques for analysis of histone modifications
are ready for use on the types of samples that have typically
been collected in population-based studies, such as blood,
buccal swabs, newborn dried blood spots, or formalin-fixed
and paraffin-embedded (FFPE) samples. Therefore, most
studies have relied almost exclusively on the analysis of
DNA methylation, which can be performed on small
quantities of extracted DNA. Even heavily cross-linked and
degraded DNA obtained from FFPE samples can be
interrogated for the distribution of methylation marks.
Investigation of epigenetic mechanisms requires con-
sideration of specific type or types of cells to be studied,
since normal epigenetic state varies between cell types (Wu
et al. 2011). For many diseases and exposures, the relevant
affected cells or tissue may not be readily accessible or
even known. The cell types of greatest relevance are
unlikely to be represented in extant biorepositories
assembled for genetic research, for which most nucleated
cells suffice, making minimally invasive collection a pri-
mary consideration. Proxy tissue may in special circum-
stances be useful following deliberate validation (Talens
et al. 2010). Where cells of greatest relevance are collected
several concerns remain: there may be ethical barriers to
obtaining relevant cells from unaffected control individuals
or even from cases; cells may not be sufficiently abundant
or amenable to separation from surrounding tissue; and if
disease processes alter proportions of normal cells spurious
associations between epigenetic state and disease may
occur on the basis of normal epigenetic profiles alone (Wu
et al. 2011).
Statistical methods
Statisticians have developed various methods for disen-
tangling imprinting, parent-of-origin, and maternal–fetal
interaction effects in family data (Ainsworth et al. 2011).
These generally entail extensions of the transmission-dis-
equilibrium test, which seeks departures in genotype dis-
tributions among affected offspring from expected
distributions given their parents’ genotypes. The standard
test ignores differences between the two parents, so that
aA 9 aa and aa 9 aA mating types would be considered
interchangeable. However, by adding additional terms to
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the conditional likelihood to distinguish between maternal
and paternal alleles, as well as interactions between
maternal and offspring genotypes and by incorporating
grandmaternal genotypes, it may be possible to separate
these phenomena. Rather than the standard likelihood
framework for family-based association studies, Weinberg
and colleagues (Vermeulen et al. 2009) have developed a
flexible log-linear modeling framework based on the joint
distribution of mating types and offspring genotypes and
extensions to include grandparental genotypes. One par-
ticularly important development is the ‘‘pent’’ design
(Mitchell and Weinberg 2005) for studying maternal–fetal
interactions, entailing genotypes of a mother, her offspring,
her spouse, and her parents; in this design, paternal
grandparents are not needed, as their mating type can be
imputed. However, none of these methods directly incor-
porate measured epigenetic states.
Development of statistical methods for analysis of DNA
methylation, the most frequently measured epigenetic
mark, has been dispersed across applications using differ-
ent technologies. Although a large body of work is starting
to accumulate for microarrays, there are still three major
platforms in use, each with their own statistical analysis
methods (see Siegmund 2011 for a review). Cross-platform
adaptation of some methods (e.g., subset quantile normal-
ization Aryee et al. 2011) is an area of current
investigation.
Most methods for biological analyses focus on either
searching for new disease subtypes through cluster analysis
(Clifford et al. 2011; Siegmund et al. 2004), or looking for
areas of differential DNA methylation between samples
under different conditions (Jaffe et al. 2012a; Langevin
et al. 2011). Sometimes differential DNA methylation is
defined by differences in variation, rather than a shift in the
mean (Jaffe et al. 2012a).
There has been relatively little emphasis on modeling
epigenetic state as an intermediate variable. In one such
example, however, Siegmund et al. (2006) used a finite
mixture model to estimate the association between expo-
sure and latent disease subtype measured by DNA meth-
ylation profiles and compared these results with a simpler
two-phase approach, first clustering the DNA methylation
data and then relating these clusters to exposure using
logistic regression.
Several authors (Furrow et al. 2011; Slatkin 2009; Tal
et al. 2010) have developed models of epigenetic inheri-
tance that allow epigenetic state to be reset between gen-
erations, as well as environmental induction and
environment-sensitive modifications. They have shown
that variation in either the environmental or the epigenetic
state could produce high heritability, comparable to the
heritability expected from purely genetic effects. These
papers, however, are focused more on theoretical
assessment of how much of the ‘‘missing heritability’’
could be due to epigenetics rather than providing methods
for analysis of epidemiologic data. We therefore briefly
outline a general framework that could be used for this
latter purpose. Details and supporting simulation studies
will be described completely elsewhere.
One approach could be to treat an individual’s epige-
netic state as a time-dependent latent process, li(t), which
is only partially observed at particular time points tk by
flawed assays Mik. Using standard measurement error
modeling approaches, one might then treat the latent pro-
cess as being determined by one’s constitutional genotype
Gi and exposure history Ei(t), through a linear longitudinal
random-effects model, with the latent process in turn being
a risk factor for disease state Yi(t), through a standard
survival analysis model (see, for example, Elashoff et al.
2007) for similar latent process methods applied to longi-
tudinal data on CD4 cell counts in relation to AIDS inci-
dence). To address the high-dimensional nature of
epigenetic data, one could use the kinds of cluster-analysis
techniques described by Siegmund et al. (2006), treating
the cluster rather than individual epigenetic marks, as a
latent risk factor for disease (see Molitor et al. 2003 for an
example of similar latent cluster methods applied to hap-
lotype associations).
To address transgenerational phenomena, we propose an
extension of this approach illustrated in Fig. 2. In this
model, grandparental genetic and environmental effects
(Gmm,Emm etc.) are transmitted to the parents via trans-
mitted epigenotypes (Gmm* etc.), which are modified by the
parents’ environments and in turn transmitted to the off-
spring generation to determine their phenotypes, in com-
bination with their own exposures at the relevant
developmental stage.
Extending to genome-wide scale
Much of the early work on the role of epigenetics in disease
has focused either on global methylation, differentially
methylated regions associated with several imprinted loci,
or promoter regions of selected candidate genes. Now,
facilitated by the advent of high-density methylation arrays
like the Illumina Infinium Beadarray that can interrogate up
to 480K CpG sites, the kinds of agnostic genome-wide
scans that have become popular for investigating germline
genetic variation [genome-wide association scans
(GWAS)] are likely to become widely used for epigenetics
as well. There are two forms such studies could take. The
first is a genome-wide scan for epigenetic variation in
relation to disease risk—what has recently been called an
epigenome-wide association scan (EWAS) (Rakyan et al.
2011) (this should not to be confused with the use of the
same acronym for exposure-wide association scans, Patel
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et al. 2010). For example, in an agnostic scan of 92 head
and neck cancers and 92 controls, 6 CpG loci were iden-
tified (Langevin et al. 2012). Here, the focus was on finding
biomarkers that might be useful for early detection rather
than for etiologic inference. Case–control designs are
commonly used in GWAS studies, wherein measured
biomarkers of interest are genotypes that do not change
over time and are presumed to be identical in all nucleated
cells of each individual. EWAS for etiology are far more
challenging for two fundamental reasons. First, use of
retrospective case–control designs introduces the possibil-
ity of ‘‘reverse causation,’’ wherein the disease or its
treatment causes epigenetic changes rather than the
reverse. Second, tissue and cell type specificity of epige-
netic marks measured in EWAS pose the issues of sample
collection and interpretation described in the previous
section.
A different example, provided by an EWAS of the effect
of smoking on methylation (Breitling et al. 2011), which
found lower methylation at a CpG site in F2RL3 in
smokers than nonsmokers, avoids the problem of reverse
causation, but not of tissue specificity.
The second approach to agnostic genome-wide epige-
netic research uses methylation quantitative trait loci
(mQTLs). These seek genome-wide SNP variation associ-
ated with genome-wide epigenetic state (Bell et al. 2011a)
in a manner similar to expression QTL (eQTL) studies.
Studies of mQTLs offer the potential to detect both cis-
associations (SNPs in or near a gene that are associated
with epigenetic state of the same gene) and trans-associa-
tions (associations with epigenetic state of genes located at
some distance from the SNP or on separate chromosomes).
Although the vast majority of associations in HapMap cell
lines studied by Bell et al. were of the cis type, they found a
trans association of a SNP in the DIP2B gene (thought to
be involved in DNA methylation) with the first principal
component of genome-wide methylation.
EWASs pose novel statistical challenges for peak
detection that differ from other applications of this tech-
niques (such as for ChIPseq data), as summarized by Jaffe
et al. (2012b). Not only a larger number of individuals
studied, but the correlation structure from adjacent probes
on the microarray is more complex, peaks are expected to
be more variable in size and shape and in certain appli-
cations more numerous (requiring different approaches for
multiple comparisons) and there can be more serious
measurement error problems. Jaffe et al. propose a novel
‘‘bump hunting’’ technique to address such problems.
Another challenge concerns the problem of reverse cau-
sation mentioned above. In studies of the association of
biomarkers with disease, the technique of Mendelian ran-
domization (Davey Smith and Ebrahim 2004) has received
much attention as a way of overcoming reverse causation
and uncontrolled confounding by using a gene as an
instrumental variable (Greenland 2000) to assess the causal
effect of the biomarker on disease risk. Relton and Davey
Smith (2012) have proposed a novel two-step extension of
this idea for methylation studies, using two genes as
Fig. 2 Schematic
representation of the model for
transgenerational effects
Hum Genet (2012) 131:1565–1589 1577
123
instrumental variables, one to estimate the exposure–
methylation association, the other to estimate the methyl-
ation–disease association.
Epidemiological opportunities
Despite the wealth of research on the role of epigenetics in
disease, there has been much less activity on the environ-
mental determinants of epigenetic changes and their role of
epigenetic state in mediating exposure–response relation-
ships, either within individuals or across generations.
Rakyan et al. (2011) provide an excellent review of some
of the design issues in epigenetic epidemiology. Here we
focus on some opportunities for further epidemiologic
study in this area.
Case–control and cohort studies
Studies of the genetic determinants of disease, whether
based on candidate site hypotheses, pathway-based
hypotheses, or GWAS technology, have utilized cross-
sectional studies in what is conceptually a case–control
approach, since the ‘‘exposures’’ in question were geno-
types presumed to be immutable. Analogous studies of
disease outcomes in light of epigenetic alterations, how-
ever, are fundamentally flawed, not only because earlier
causal events could always be responsible for observed
epigenetic change, but also because any stage in the
pathophysiology of the disease and/or any treatment prior
to sample collection could itself generate epigenetic
change. De novo cohort studies of the genetic determinants
of disease require biosamples at the outset, are slow to
yield results, and often prohibitively expensive, because
the rare outcomes of greatest interest can only be assessed
if the genomic subsets are very large. Cohort studies of the
causation of endpoint phenotypes or even intermediary risk
factors by epigenetic characteristics are likely to be just as
difficult. Moreover, observational studies of human epi-
genetic events as usually conducted are confounded by age,
genomic characteristics, and the earlier environmental
milieu, including the prepartum component.
One can, however, study epigenetic alterations as out-
comes, and by so doing, come to understand their role as
intermediary agents between disease outcomes and the
toxic agents known to cause them. Cross-sectional studies
of cells from exposed and unexposed individuals are
interpretable under the assumption that the epigenetic
alterations are unlikely to have produced the behavior that
led to the toxic exposure. Over the long term, comparison
between the epigenetic experiences of exposed and unex-
posed cohorts will require repeated epigenetic character-
ization of persons with particular toxic exposures or
particular characteristics, such as jobs that stand as surro-
gate measures of such exposure.
Twin studies
In contrast to observational studies of singletons, twin
studies can provide several advantages for studies of epi-
genetics (Bell and Saffery 2012). Monozygotic twins are in
effect matched on age, complete genome, and childhood
environment and cultural milieu. By contrast, even mono-
zygotic twins can be considered only partly matched on
intrauterine environment. Because epigenetic events occur
at various points throughout gestation, epigenetic state at
birth is probably influenced by chorionicity and possibly as
well by characteristics of the amnion and the anatomy of
implantation.
Differences between the global and gene-specific epi-
genetic states of adult identical twins have been described
in numerous studies (Bell et al. 2012; Bocklandt et al.
2011; Boks et al. 2009; Fraga et al. 2005; Heijmans et al.
2007), suggesting that epigenetic state changes with age, or
more accurately, with cohort, since these were all different
people. Methylation state at some CpG sites is highly
predictive, as shown in a recent study that identified
numerous methyl marks in DNA isolated from saliva to be
highly associated with age. In a validation set of study
participants, methylation state at only two of the identified
CpG sites explained 73 % of the variance in age over a
5-decade range (Bocklandt et al. 2011). Such epigenetic
marks may prove useful not only in understanding bio-
logical process associated with aging, but also as tools for
classifying participants in research into biologically based
age groups. For example, individuals with large differences
between epigenetically predicted age and chronological
age might be considered to have unusual physiologic state
or bio-age.
However, unless age-specific epigenetic states are
demonstrated in the same twins studied across different
ages, as has been done in singletons (Bjornsson et al.
2008), apparent effects of age on epigenetic state may be
confounded by birth cohort-specific differences in exposure
history. In a study of identical twin children observed at
both ages 5 and 10, prevalence of DNA methylation at
selected promoter sites changed measurably over time
(Wong et al. 2010), as did prevalence of more extreme
skewing of X chromosome inactivation within some
female pairs (Wong et al. 2011). Observed concordance
between co-twins of changes in such measures provide
information regarding factors that may influence epigenetic
changes that is not available from singletons. For example,
observing little concordance of within-pair changes in X
chromosome inactivation, Wong et al. (2011) concluded
that alterations in these patterns between 5 and 10 years of
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age are unlikely to be influenced by factors shared by
twins. Establishment of cohorts to be periodically moni-
tored for epigenetic changes should provide further docu-
mentation of age-specific changes (Saffery et al. 2011).
Identical twins discordant for both epigenetic state and a
putatively toxic exposure or adverse circumstance can
therefore be used to tentatively identify factors that cause
or facilitate epigenetic change. For example, in a study
comparing members of monozygotic dichorionic twin
pairs, DNA from placental tissue of smaller co-twins was
found to have lower prevalence of promoter DNA meth-
ylation at the human endogenous retroviral family W
Env(C7) member 1 gene (HERVWE1). Moreover, mRNA
and protein encoded by HERVWE1 was more highly
expressed in placental tissue of smaller co-twins (Gao et al.
2012).
Studies identifying differences in epigenetic state
between identical twin pairs discordant for a trait or disease
phenotype can raise provocative etiologic questions.
However, as in case–control studies of phenotypic out-
comes in general, these studies must be interpreted with
caution, particularly if the chronology of relevant expo-
sures, occurrence of epigenetic changes, and onset of
pathophysiologic processes is unclear, if the variable locus
is not known to function in the pathogenic pathway, or if
the disease pathology is not manifested in the tissue in
which epigenetic state is measured. Such provocative
questions have been raised by studies of trait-discordant
monozygotic twins in relation to differential X-inactivation
in the context of bipolar disorder (Rosa et al. 2008) and
primary biliary cirrhosis (Mitchell et al. 2011), and dif-
ferential DNA methylation at specific loci in the context of
a caudal duplication anomaly (Oates et al. 2006), bipolar
disorder (Dempster et al. 2011; Kuratomi et al. 2008),
schizophrenia (Dempster et al. 2011), and BRCA1-related
malignancy (Galetzka et al. 2012). Global changes in
methylation, to differing degrees, have been reported in
identical twins discordant for psychometric evidence of
aberrant personality (Kaminsky et al. 2008), Alzheimer’s
disease (Mastroeni et al. 2009), systemic lupus erythema-
tosus (Javierre et al. 2010), autism (Nguyen et al. 2010a),
and inflammatory bowel disease (Harris et al. 2012). A
comprehensive global search for differences between (only
three pairs of) twins discordant for multiple sclerosis was
unsuccessful, possibly because peripheral white blood cells
were used (Baranzini et al. 2010). Differences in gene
expression between trait-discordant identical twins, pre-
sumably reflecting epigenetic differences, have been
observed for rheumatoid arthritis (Haas et al. 2006), bipolar
disorder (Matigian et al. 2007), schizophrenia (Kakiuchi
et al. 2008), type 1 diabetes (Beyan et al. 2010), diverse
systemic autoimmune conditions (O’Hanlon et al. 2011),
and psoriasis (Gervin et al. 2012).
Twins have also been used to suggest the existence of
heritable determinants of epigenetic change. The tradi-
tional design is based on the comparison of proband-wise
concordance between monozygotic twins with that
between like-sex dizygotic twins, separating the variance
attributable to the environment from that attributable to the
additional half of the genome held in common between
monozygotic twins. Reservations about conclusions from
such studies are based on two considerations. The first
concerns the assumption that the sharing of the monozy-
gotic twins’ environment is identical to that of dizygotic
twins—an assumption necessary for heritability to be
estimable from twin studies. This assumption is suspect in
adulthood, since dizygotic twins tend to diverge geo-
graphically and socially to a greater extent than do
monozygotic twins, and since any monozygotic twin is
more likely than a dizygotic twin to perceive and adopt a
behavior seen to be advantageous to the co-twin. This is
compounded by the second concern, namely the inevitable
variability in the twin concordance of a phenotype that is
also determined by a geographically, chronologically, or
socially variable environmental exposure. Thus, the reli-
ability of any such estimate is highest for phenotypes that
are not confounded by age, time, and place, and especially
for those of young children that have no behavioral
determinants.
Moreover, when comparisons of twin concordance are
used to estimate the heritability of an epigenetic trait,
necessary caveats are more numerous. Heritability of epi-
genetic traits is clearly tissue specific, and likely to be locus
specific as well. Because of the influence of the intrauterine
environment and the fact that they exchange blood cells,
monochorionic identical twins cannot be considered com-
parable to dizygotic twins, and comparisons should be
based only on dichorionic monozygotic pairs. Irrespective
of chorionicity, identical twins begin life as a single zygote,
restricting the number of early cell-days at risk of inde-
pendent epigenetic change relative to the separate zygotes
of dizygotic twins.
Initial attempts at demonstrating heritability at specific
loci by these methods have had some limited success (Boks
et al. 2009; Breton et al. 2011c; Coolen et al. 2011; Heij-
mans et al. 2007; Schneider et al. 2010), but investigations
of larger portions of the epigenome in specific tissues have
shown only a marginal increase in epigenetic similarity
between the members of monozygotic twin pairs, com-
pared with dizygotic twin pairs (Gervin et al. 2011; Olli-
kainen et al. 2010).
Multigenerational studies
In the remainder of this section, we discuss a few of the
unique exposure settings that might be useful for exploring
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the role of epigenetics in apparent transgenerational
exposure phenomena.
Famine cohorts
Testis cancer incidence has been increasing for decades,
and age–period–cohort analyses consistently demonstrate
that birth year is an important determinant of testicular
cancer risk. Based on these findings, exposure to uniden-
tified environmental causes is postulated to be increasing,
with observed birth cohort effects attributed to early action
of such exposures. The singular exception to this pattern is
a dip in incidence among men born in Europe during World
War II (Moller et al. 1995). Postulated epigenetic mecha-
nisms related to energy intake in the in utero and perinatal
periods warrant investigation among individuals gestated
during famine and their descendents.
Child health and development studies
The California Child Health and Development Studies
(Cohn 2011; van den Berg et al. 1988) were launched
between 1959 and 1967 with the enrollment of a cohort of
about 20,000 pregnancies, with follow-up of the parents
and offspring through the present day. Biological speci-
mens were provided by both parents and the child at the
time of enrollment, along with limited questionnaire
information about grandparental exposures, and longitudi-
nal samples have also been obtained. As these children are
now in their 50s, many have themselves had children, who
have also been enrolled in the study, and grandchildren are
already starting to be born. This cohort thus represents a
unique opportunity to study transgenerational epigenetic
phenomena, such as their studies of maternal exposures to
DDT.
Diethylstilbestrol offspring
DES is regarded as a potential environmental endocrine
disruptor by many researchers because this compound
binds steroid hormone receptors and has only exogenous
sources. Because exposure occurred only in relatively
controlled clinic settings, cohorts of exposed individuals
could in theory provide an opportunity to trace any epi-
genetic effects of exposure among themselves and their
descendents to the restricted time periods of their preg-
nancies or gestation before administration to pregnant
women ended in the 1970s. Exposure and comparison
group data of varying quality are or could be made avail-
able from several sources, the highest quality in theory
being participants in trials of DES efficacy conducted in the
1950s (Dieckmann et al. 1953; Ferguson 1953), although
sample sizes were limited. Nonetheless, the numerous
case–control sets, DES-exposed cohorts, and interest
groups that subsequently enrolled large numbers of
exposed men and women to monitor and investigate health
effects of exposed individuals (Swan 2000) could prove to
be valuable resources for investigation of potential epige-
netic and transgenerational effects of DES among exposed
individuals and their descendents. Initial proof-of-concept
studies could include investigation of epigenetic marks
postulated to have been disrupted by DES exposures.
Assisted reproductive technologies
In industrialized countries 1–4 % of neonates are now
conceived by ART. Intensive surveillance of long-term
health of these children has revealed somewhat increased
occurrence of numerous disorders (Savage et al. 2011).
However, a desirable next step in this research—deter-
mining whether ART procedures or indications for these
procedures (parents’ infertility or subfertility) account for
excess risk—is severely limited by paucity of data on
children with a history of only one of these factors. Epi-
genetic mechanisms are commonly postulated for both
ART and parental origins of several ART-associated con-
ditions, including model imprinting disorders and IUGR.
Therefore, new studies aiming to trace candidate epigenetic
marks from relevant cells of the parent (e.g., father’s
sperm) to those of affected ART-conceived children (e.g.,
placenta of IUGR infants or somatic cells of children with
Prader-Willi syndrome) seems a logical first step to sepa-
rating treatment effects from indication. More generally,
studies comparing the epigenetic state of relevant cells
from children conceived by ART with that of like-cell
types from naturally conceived children may provide
additional insights regarding conditions in early develop-
ment, particularly conditions over-represented among
children conceived by ART. Ongoing surveillance will
doubtlessly reveal whether later onset conditions are added
to this list as cohorts of children conceived by ART achieve
ages at risk of diseases of adulthood. A logical extension of
this surveillance would be to determine among descendents
the presence of relevant phenotypes and epigenetic marks.
Conclusions
Noteworthy experimental results, taken together, indicate
that epigenetic processes could plausibly mediate effects of
environmental exposures to influence disease susceptibility
in mammals, since (1) specific exposures induced mea-
surable changes in epigenetic state, (2) new epigenetic state
was shown to persist after cessation of exposure, and (3)
measureable phenotype was associated with exposure-
related changes in epigenetic state. A fourth element,
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exposure-induced alteration of epigenetic marks of germ
cell lineage DNA, seems necessary for transgenerational
transmission of environmentally induced epigenetic chan-
ges. On this background, we interpret observational human
data illustrating associations of exposures to epigenetic
state and epigenetic state to disease to indicate that epi-
genetic mechanisms may plausibly mediate exposure
effects on a wide range of human diseases.
Perhaps the greatest significance of this line of research
is the potential for designing novel interventions articulated
by Dolinoy and Jirtle (2008):
unlike genetic mutations, epigenetic profiles are
potentially reversible. Therefore, epigenetic approa-
ches for prevention and treatment, such as nutritional
supplementation and/or pharmaceutical therapies
may be developed to counteract negative epigenomic
profiles.
As an example, Huang et al. (2012) have developed a
therapy for reactivating the Ube3a allele that is epigeneti-
cally silenced in Angelman syndrome. However, before we
begin to realize this translational potential, much research
along parallel tracks needs to be conducted.
We need to better understand basic epigenetic mecha-
nisms that operate during selected periods when the epi-
genome may be particularly vulnerable to environmental
exposures (e.g., prenatal and early postnatal periods,
childhood, puberty) as well as mechanisms that routinely
maintain proper epigenetic states. We also need to under-
stand mechanisms relevant to cumulative effects of expo-
sure and associations with aging, since duration of
exposure and aging are co-linear. A better understanding of
basic mechanisms at different time points in life would
guide genetic epidemiology studies in selecting environ-
mental exposures that are more likely to affect epigenetic
processes, identify the most relevant periods of exposure,
identify biomarkers of exposure, and suggest biological
intermediates to study.
It may be helpful to more deliberately deconstruct the
steps whereby an environmental exposure may affect risk
of disease via epigenetic mechanisms. For example, studies
of the association of environmental exposures with selected
epigenetic events as endpoints (rather than intermediates in
a complex pathway) may be fruitful and will likely help us
better conceive of studies to elucidate an entire pathway,
from an exposure acting at least in part through epigenetic
mechanisms to disease risk.
As we proceed, it will be important to consider seriously
the environmental exposures to study, since we will want to
select the most promising candidate exposures (those most
likely to affect epigenetic processes), measuring these
exposures at relevant time periods and with reasonable
accuracy. Also, we cannot ignore genetic influences on
epigenetic processes. We see above that studies of the
epigenetic state of specific candidate genes are yielding
interesting results and more such studies are warranted.
Given limited knowledge of this genetic–epigenetic inter-
face, to complement the candidate gene approach, inte-
grative genomics approaches should be contemplated in
order to combine GWAS data with epigenomic data.
Clearly, statistical and bioinformatics approaches will be
required to enable the efficient conduct of these analyses,
especially as we expand to genome-wide scale. Similarly,
research on feasible, efficient study designs, akin to current
research on optimum designs for sequencing-based studies,
will be needed. Finally, as with other emerging fields (e.g.,
the standardization of testing criteria for microsatellite
instability or MSI), standardization of terminology and
testing protocols will facilitate future communication of
hypotheses, scientific approaches, and results.
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